Design, expression and characterization of a single chain anti-CD20 antibody; a germline humanized antibody derived from Rituximab - ScienceDirect
Sequence analysis of Rituximab-VH. Contributions to the total score are... | Download Scientific Diagram
Frontiers | Past, Present, and Future of Rituximab—The World's First Oncology Monoclonal Antibody Therapy
Application Note: Characterization of Rituximab by Conformational Epitope
Cellular and molecular signal transduction pathways modulated by rituximab ( rituxan, anti-CD20 mAb) in non-Hodgkin's lymphoma: implications in chemosensitization and therapeutic intervention | Oncogene
![PDF] The epitope recognized by rituximab. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/6f42276ab0369b00580794ea75979d89babf37fe/2-Table1-1.png "PDF] The epitope recognized by rituximab. | Semantic Scholar")
PDF] The epitope recognized by rituximab. | Semantic Scholar
Rituximab theoretical structure based on data reported in public... | Download Scientific Diagram
R-CHOP, radioimmunotherapy, and maintenance rituximab in untreated follicular lymphoma (SWOG S0801): a single-arm, phase 2, multicentre study - The Lancet Haematology
Use of rituximab in paediatric nephrology | Archives of Disease in Childhood
BioLegend - Rituximab antibody therapy targets CD20 on B... | Facebook
1-year results of treatment with rituximab in polymyalgia rheumatica: an extension study of a randomised double-blind placebo-controlled trial - The Lancet Rheumatology
The primary, secondary and tertiary structures of the two IgG1... | Download Scientific Diagram
Aptamers as quality control tool for production, storage and biosimilarity of the anti-CD20 biopharmaceutical rituximab | Scientific Reports
Amino acid sequence of heavy chain (top) and light chain (bottom)... | Download Scientific Diagram
LC/MS Analysis of the Monoclonal Antibody Rituximab Using the Q Exactive Benchtop Orbitrap Mass Spectrometer
STIM1 knock‐down decreases the affinity of obinutuzumab for CD20 by altering CD20 localization to Triton‐soluble membrane - Heo - 2020 - Clinical & Experimental Immunology - Wiley Online Library
DNA sequencing reveals mechanisms of treatment resistance in patients with diffuse large B cell lymphoma | Genome Sciences Centre
The identification of irreversible rituximab-resistant lymphoma caused by CD20 gene mutations | Blood Cancer Journal
Figure 3 | Assessment of Physicochemical Properties of Rituximab Related to Its Immunomodulatory Activity
Results of middle-down analysis of rituximab digested with GingisKHAN... | Download Scientific Diagram
Structural comparison of two anti-CD20 monoclonal antibody drug products using middle-down mass spectrometry - Analyst (RSC Publishing) DOI:10.1039/C3AN36524G
Rituximab
![PDF] The epitope recognized by rituximab. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/6f42276ab0369b00580794ea75979d89babf37fe/3-Table2-1.png "PDF] The epitope recognized by rituximab. | Semantic Scholar")
PDF] The epitope recognized by rituximab. | Semantic Scholar
WO2019229677A1 - Anti-cd37 immunoconjugate dosing regimens - Google Patents
_[Rituximab_Biosimilar_1].png "JAN: Japanese Accepted Names for Pharmaceuticals")